IDET (Intradiscal Electrothermal Therapy) — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus
Quick Facts
What Is IDET (Intradiscal Electrothermal Therapy)?
Intradiscal electrothermal therapy (IDET) is a minimally invasive fluoroscopy-guided procedure designed to treat chronic low back pain arising from the intervertebral disc — a condition termed internal disc disruption or discogenic low back pain. It was developed in the late 1990s and gained popularity in the early 2000s as a non-surgical alternative for patients failing conservative management but not yet suitable for or willing to undergo spinal fusion surgery. The mechanism of IDET involves the insertion of a flexible thermal catheter (SpineCath, Smith and Nephew) into the targeted intervertebral disc through a posterolateral percutaneous approach, guided by fluoroscopy (live X-ray imaging). Once positioned along the posterior annulus fibrosus — the tough outer ring of the disc that is richly innervated with pain fibres — the catheter is gradually heated to temperatures of 65–90°C over a 16–17 minute protocol and held at maximum temperature for 4 minutes. This thermal energy is proposed to act through three mechanisms: thermocoagulation and destruction of nociceptive pain fibres embedded in the posterior annular wall; sealing and contraction of collagen fibres within annular fissures to stabilise micro-tears; and modulation of the immune-inflammatory response within the damaged disc. The procedure is performed as an outpatient with local anaesthesia and intravenous sedation. Its evidence base remains controversial — early observational series were promising but subsequent randomised controlled trials produced conflicting results. IDET use has substantially declined in the past decade as the evidence base has matured and alternative spinal interventions have emerged.
Who Needs This Procedure?
IDET is applicable to a very narrow, carefully selected patient population when considered at all. The traditional selection criteria, developed from the original observational case series and refined through trial experience, require all of the following: chronic low back pain of discogenic origin lasting at least 6 months without significant improvement with evidence-based conservative management (a structured physiotherapy programme including core stabilisation and McKenzie technique, appropriate analgesic management including NSAIDs and low-dose antidepressants, and a supervised graded activity programme); a positive provocative discography at the affected level demonstrating concordant pain reproduction at low pressure (intradiscal pressure below 50 psi above opening pressure) with a morphologically abnormal disc on post-discography CT — confirming the disc as the primary pain generator; preservation of at least 50% of normal disc height on MRI, as collapsed discs do not allow the catheter to be positioned correctly; absence of significant neural compression, radiculopathy, or disc herniation (IDET treats central discogenic pain, not nerve root compression); and failure of all conservative measures including physiotherapy, analgesic medications, and injection therapy. IDET is not a standard-of-care treatment and should not be offered outside of specialist spine centres with appropriate patient selection pathways. Current NICE, EAU, and NASS (North American Spine Society) guidelines do not endorse IDET as routine practice. Patients considering IDET should understand that robust evidence of efficacy is lacking and discuss surgical alternatives including minimally invasive lumbar fusion procedures.
How the Procedure Is Performed
IDET is performed in a fluoroscopy suite under sterile conditions with the patient prone. Intravenous sedation (midazolam and fentanyl or propofol infusion) and local anaesthetic infiltration at the skin entry point are used; the patient must be conscious enough to report any pain during the procedure to avoid inadvertent nerve injury. Under continuous biplane fluoroscopic guidance, a 17-gauge introducer needle is inserted via a posterolateral approach to the targeted disc, entering at an angle to place the needle tip at the posterior annulus. The needle trajectory is confirmed in both anteroposterior and lateral fluoroscopic views. Once the introducer is correctly positioned at the disc margin, the SpineCath flexible resistive coil catheter — a steerable catheter of 0.9 mm diameter containing a resistive heating element — is advanced through the needle and navigated around the inner circumference of the posterior annulus fibrosus using its inherent curl and gentle manipulation. Correct catheter position — coiled along the full posterior third of the annulus — is confirmed fluoroscopically before heating begins. A dedicated generator controls the heating protocol: temperature ramps from 65°C up to 90°C over 16 minutes at 1°C increments, then holds at 90°C for 4 minutes. The patient is monitored for any neurological symptoms throughout. After the heating cycle, the catheter and introducer are removed. An intradiscal injection of prophylactic antibiotic (typically cephalosporin) is administered before needle removal to reduce discitis risk. A sterile dressing is applied. The entire procedure takes 30–60 minutes; patients are observed for 1–2 hours before discharge. The procedure is performed at one disc level per session; multilevel disease may be treated at separate sittings.
Results and Success Rates
The evidence base for IDET demonstrates a wide range of outcomes depending on patient selection, study design, and outcome measures used. Early uncontrolled observational series, including the original Saal and Saal series (2000), reported that 60–80% of selected patients achieved clinically meaningful improvements in pain (VAS scores) and functional outcomes (SF-36) at 12 months follow-up. A subsequent multicentre prospective study confirmed these results in carefully selected patients with preserved disc height, positive discography, and a minimum 6-month trial of conservative management. However, randomised controlled trial evidence has been far less consistent. The Pauza et al. RCT (Spine, 2004) comparing IDET to a sham procedure demonstrated modest but statistically significant improvements in pain (average 2-point VAS improvement) and function in the IDET group versus sham, supporting some degree of therapeutic effect. In contrast, the larger Freeman et al. RCT (Spine, 2005), a blinded multicentre UK trial, showed no significant difference between IDET and sham treatment for the primary pain outcome, calling into question whether IDET has a true physiological effect above placebo. The Cochrane systematic review (2016) concluded that there is limited and inconsistent evidence to support IDET over sham treatment, with the available RCTs having methodological limitations. Given these mixed results, IDET should not be positioned as a reliable treatment but as an option that may benefit a minority of appropriately selected patients who have exhausted all alternatives short of surgery. Benefits must be discussed honestly in the context of this evidence.
Risks and Complications
IDET has a low but real complication profile that patients must understand before consent. Discitis — infection of the intervertebral disc — is the most serious complication, occurring in approximately 0.5–1% of procedures despite prophylactic intradiscal antibiotics. Discitis presents with severe escalating back pain and fever at 1–4 weeks post-procedure, is confirmed with MRI showing disc signal change, and requires prolonged intravenous antibiotics (6–8 weeks) and sometimes surgical debridement. An untreated discitis can cause vertebral osteomyelitis and permanent disc space collapse. Catheter breakage within the disc occurs in under 1% of cases and is managed by leaving the catheter fragment in situ if removal would require open surgery, as fragments are generally inert. Nerve root injury from thermal injury outside the disc or inadvertent needle placement is rare when fluoroscopic guidance is correctly used. Cauda equina syndrome — bilateral leg weakness, saddle anaesthesia, and bowel or bladder dysfunction — is an extremely rare but reported complication of incorrect catheter placement near the posterior longitudinal ligament. Failure to achieve any meaningful pain reduction — the most common outcome in randomised trial populations — is itself a significant risk that must be discussed: the procedure is invasive, has a recovery period, and carries genuine medical risks without a reliable probability of benefit in the general population. Accelerated disc space narrowing has been observed in some patients in the years following IDET and may complicate subsequent surgical planning.
Recovery and Aftercare
Following the procedure, patients are observed for 1–2 hours before discharge. A rigid or semi-rigid lumbar corset is prescribed and worn for 6–8 weeks to protect the treated disc during the initial healing phase. Activity restriction is comprehensive in the early recovery period: bending at the waist, lifting over 2–3 kg, prolonged sitting (more than 20–30 minutes without a break), and all rotational spinal movements are restricted for 8–12 weeks. Patients work from home in a recumbent or standing position during early recovery. Driving is not recommended for the first 4–6 weeks. Low-impact walking is encouraged from the first week and progressively increased as tolerated. Formal physiotherapy focusing on core stabilisation, lumbar stabilisation exercises, and neural mobilisation begins at 4–8 weeks post-procedure. Swimming and cycling may resume at 8–10 weeks. Return to desk work in a well-supported ergonomic chair typically occurs at 6–8 weeks. Physical labour is deferred for a minimum of 3–4 months. Clinical benefit, if present, develops gradually over 3–6 months as collagen remodelling and nerve fibre destruction complete their effects — patients must be counselled that improvement is not immediate and that early pain after the procedure does not indicate failure. Follow-up appointments at 6 weeks, 3 months, and 6 months allow assessment of pain and functional outcomes with validated outcome tools (VAS, ODI, SF-36). If no meaningful benefit is apparent at 6 months, surgical consultation for minimally invasive lumbar fusion is the appropriate next step.
Frequently Asked Questions
References
- Cochrane Review — Intradiscal Electrothermal Therapy for Chronic Discogenic Low Back Pain, 2016
- Freeman BJ et al. — A randomised, double-blind, controlled efficacy study of IDET vs. sham procedure for the treatment of chronic discogenic low back pain, Spine, 2005
- European Spine Journal — Intradiscal Therapies Review: Current Evidence and Future Directions, 2024
Medically Reviewed
Our medical content follows strict editorial guidelines to ensure accuracy and reliability.
Up to Date
Last updated: 2026-07-07
Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.
Ready to take the next step?
Connect with top hospitals and specialists. Get personalized guidance for your medical journey.